ProfileGDS4132 / 205199_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 48% 47% 52% 42% 49% 51% 47% 58% 42% 43% 34% 33% 36% 41% 34% 33% 30% 40% 42% 31% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101128.04248
GSM201543Muscle PCOS pioglitazone 121117.57147
GSM201544Muscle PCOS pioglitazone 161141.74652
GSM201545Muscle PCOS pioglitazone 201118.28142
GSM201829Muscle PCOS pioglitazone 231139.30949
GSM201830Muscle PCOS pioglitazon 251143.53351
GSM201831Muscle PCOS pioglitazone 271124.37847
GSM201832Muscle PCOS pioglitazone 31155.22358
GSM201833Muscle PCOS pioglitazone 41101.01942
GSM201834Muscle PCOS pioglitazone 81109.17143
GSM201835Muscle PCOS after pioglitazone 10270.886534
GSM201836Muscle PCOS after pioglitazone 12270.961733
GSM201837Muscle PCOS after pioglitazone 16276.698436
GSM201838Muscle PCOS after pioglitazone 20294.960541
GSM201839Muscle PCOS after pioglitazone 23277.864934
GSM201840Muscle PCOS after pioglitazone 25280.083833
GSM201841Muscle PCOS after pioglitazone 27259.482130
GSM201842Muscle PCOS after pioglitazone 3284.426540
GSM201843Muscle PCOS after pioglitazone 42104.40142
GSM201844Muscle PCOS after pioglitazone 8271.52231